|

Arthritis Clinical Trials in Mesa, AZ

36 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic DrugPhase 3<1 mi
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial DiseasePhase 4<1 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)Phase 4<1 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponsePhase 3<1 mi
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic ArthritisPhase 3<1 mi
A Study of Dotinurad Versus Allopurinol in Participants With GoutPhase 3<1 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightPhase 3<1 mi
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)Phase 2<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesPhase 3<1 mi
Study of Dapansutrile Tablets in Subjects With an Acute Gout FlarePhase 2/3<1 mi
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic ArthritisPhase 3<1 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the KneePhase 35 mi
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic PainPhase 25 mi
FX Shoulder Prospective Clinical Study—5 mi
FX Shoulder Solutions Retrospective / Prospective Clinical Study—5 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)Phase 35 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesPhase 38 mi
Study of Single Doses of SBT777101 in Subjects With Rheumatoid ArthritisPhase 18 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee OsteoarthritisEarly 18 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar PainPhase 18 mi
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune DiseasesPhase 28 mi
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.Phase 214 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry—14 mi
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.Phase 314 mi
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid ArthritisPhase 114 mi
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement—14 mi
Innovations in Genicular Outcomes Registry—14 mi
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid ArthritisPhase 222 mi
At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]N/A22 mi
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsPhase 126 mi
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.Phase 326 mi
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisPhase 226 mi
RA-PRO PRAGMATIC TRIALPhase 326 mi
Safety and Efficacy of ABP-745 in Participants With an Acute Gout FlarePhase 226 mi
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)Phase 226 mi
A Study of SPY072 in Rheumatic DiseasePhase 230 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.